Home › Bile Duct Cancer (Cholangiocarcinoma)

Bile Duct Cancer (Cholangiocarcinoma) clinical trials recruiting in the U.S.

56 studies for Bile Duct Cancer (Cholangiocarcinoma) are recruiting participants at sites across the United States.

Cities with the most studies

• Houston, TX13 studies
• New York City, NY11 studies
• Boston, MA8 studies
• Rochester, MN7 studies
• Arlington, VA7 studies
• Los Angeles, CA7 studies
• Chicago, IL7 studies
• Columbus, OH6 studies
• Cleveland, OH6 studies
• Edison, NJ5 studies
• Queens, NY5 studies
• Grand Rapids, MI5 studies
• Nashville, TN5 studies
• Tampa, FL5 studies
• San Antonio, TX5 studies
• Philadelphia, PA5 studies
• Miami, FL5 studies
• Dallas, TX5 studies
• Mountain View, CA5 studies
• Baltimore, MD5 studies
• Baldwin Park, CA5 studies
• Washington, DC5 studies
• Orange, CA4 studies
• St. Louis, MO4 studies
• Durham, NC4 studies
• Seattle, WA4 studies
• Detroit, MI4 studies
• New Haven, CT4 studies
• Atlanta, GA3 studies
• West Valley City, UT3 studies
• Jacksonville, FL3 studies
• Salt Lake City, UT3 studies
• Buffalo, NY3 studies
• Birmingham, AL3 studies
• San Francisco, CA3 studies
• Louisville, KY3 studies
• Santa Monica, CA3 studies

By state

• Alabama3 studies
• Arizona3 studies
• California20 studies
• Colorado3 studies
• Connecticut6 studies
• Florida13 studies
• Georgia3 studies
• Illinois8 studies
• Kentucky4 studies
• Maryland9 studies
• Massachusetts10 studies
• Michigan8 studies
• Minnesota10 studies
• Missouri5 studies
• New Jersey8 studies
• New York15 studies
• North Carolina6 studies
• Ohio10 studies
• Pennsylvania5 studies
• Tennessee5 studies
• Texas15 studies
• Utah6 studies
• Virginia10 studies
• Washington4 studies
• Wisconsin4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.